Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.
Kimura
Shun-Ichi
SI
Division of Hematology/Oncology, Department of Medicine, Kameda General Hospital, 929 Higashi-chou, Kamogawa, Chiba, 296-8602, Japan.
Odawara
Jun
J
Division of Hematology/Oncology, Department of Medicine, Kameda General Hospital, 929 Higashi-chou, Kamogawa, Chiba, 296-8602, Japan.
Aoki
Takatoshi
T
Division of Hematology/Oncology, Department of Medicine, Kameda General Hospital, 929 Higashi-chou, Kamogawa, Chiba, 296-8602, Japan.
Yamakura
Masayuki
M
Division of Hematology/Oncology, Department of Medicine, Kameda General Hospital, 929 Higashi-chou, Kamogawa, Chiba, 296-8602, Japan.
Takeuchi
Masami
M
Division of Hematology/Oncology, Department of Medicine, Kameda General Hospital, 929 Higashi-chou, Kamogawa, Chiba, 296-8602, Japan.
Watanabe
Yoshihiko
Y
Division of Nephrology, Department of Medicine, Kameda General Hospital, 929 Higashi-chou, Kamogawai, Chiba, 296-8602, Japan.
Matsue
Kosei
K
Division of Hematology/Oncology, Department of Medicine, Kameda General Hospital, 929 Higashi-chou, Kamogawa, Chiba, 296-8602, Japan. kmatsue@kameda.jp.
D000368:Aged; D001014:Aortic Aneurysm / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D004211:Disseminated Intravascular Coagulation / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008297:Male; D014148:Tranexamic Acid / Q000627:therapeutic use*
D014148:Tranexamic Acid